| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_96ec3985e3ce9b24614fb87bf51a4f12 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2011-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2015-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d51567ef473ead7f8f498e3170cb9d3f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd0f69fa6ca06b817bc38103e3da50d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2a3a012675f8e11348d4d516c912281
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_789c6d282dd84e31b69498a4d63bee5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1bbc97ec2faf62d034dca4e07c6bd82a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae397512ef95fc7270af27b09ee08449
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99d515db26a2099078be94d78b9de996
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41d9f0727a33c5e2966358417fcf75d2 |
| publicationDate |
2015-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2651946-B1 |
| titleOfInvention |
2-substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders |
| priorityDate |
2010-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |